Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2041 - 2048 of 11616 results
EXCLUSIVE RIGHTS: Intellectual Property — Will the Unified Patent Court Change Everything?
April 21, 2022| Podcast| Viewpoint
Massachusetts Paid Family and Medical Leave Updates – What You Need to Know
April 21, 2022| Blog| Viewpoint
Improving the Process to Distribute Retirement Benefits Pursuant to a QDRO
April 21, 2022| News
Law360's 2022 Immigration Editorial Advisory Board
April 21, 2022| News
DOJ Loses Two Criminal Antitrust Labor Trials, Stymied by (Lack of) Evidence
April 19, 2022| Blog| Viewpoint
Immigration and refugee problems persist, UM speaker argues
April 17, 2022| News
California Court Strikes Down Board Diversity Law: Now What?
April 14, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.